JOURNAL ARTICLE

Rubinstein–Taybi Syndrome With Severe Eczema, Recurrent Infections, and Hyper IgE Profile Responsive to Dupilumab Treatment.

  • Published In: Pediatric Dermatology, 2025, v. 42, n. 4. P. 826 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Nanda, Arti; Al Rushood, Maysoun; Tawfeek, Waguih W.; AlLafi, Atlal 3 of 3

Abstract

Rubinstein–Taybi syndrome (RTS) is a rare autosomal dominant disorder characterized by post‐natal growth retardation, facial dysmorphism, large thumbs and halluces, and intellectual deficits. RTS has a broad phenotypic spectrum including cardiac, genitourinary, digestive, ear, nose and throat, and skin manifestations. Patients also have an increased risk of severe infections, developing benign tumors, and immunological abnormalities suggesting primary immunodeficiencies. We report a case of RTS with severe recalcitrant eczema, recurrent skin and chest infections, food allergies associated with a hyper‐IgE profile, and other immunological abnormalities, who had a significant response to dupilumab. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Pediatric Dermatology. 2025/07, Vol. 42, Issue 4, p826
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2025
  • ISSN:0736-8046
  • DOI:10.1111/pde.15874
  • Accession Number:186996613
  • Copyright Statement:Copyright of Pediatric Dermatology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.